Ticker Details
ADMA Biologics Inc ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.
IPO Date:	October 18, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.94B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 3.02%
Avg Daily Range (30 D):	$0.17 | 1.99%
Avg Daily Range (90 D):	$0.30 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	1.6M
Avg Daily Volume (30 D):	2.42M
Avg Daily Volume (90 D):	4.81M

Trade Size
Avg Trade Size (Sh.):	169
Avg Trade Size (Sh.) (30 D):	96
Avg Trade Size (Sh.) (90 D):	116

Institutional Trades
Total Institutional Trades:	2,433
Avg Institutional Trade:	$3.5M
Avg Institutional Trade (30 D):	$5.38M
Avg Institutional Trade (90 D):	$4.31M
Avg Institutional Trade Volume:	.31M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.95M
Avg Closing Trade (30 D):	$7.7M
Avg Closing Trade (90 D):	$8.89M
Avg Closing Volume:	535.73K

News

Jul 22, 2026 @ 11:33 PM ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) In... Source: Hagens Berman

Jul 22, 2026 @ 7:48 PM ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encou... Source: Rosen Law Firm

Jul 21, 2026 @ 5:51 PM INVESTOR ALERT: Pomerantz Law Firm Reminds Investo... Source: Pomerantz Llp

Jul 20, 2026 @ 9:50 PM INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Inv... Source: Robbins Geller Rudman & Dowd Llp

Jul 20, 2026 @ 5:57 PM DEADLINE ALERT for BTGO, VIA, Z, ADMA: Law Offices... Source: Law Offices Of Howard G. Smith

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.69	$.19	$.21
Diluted EPS	$.68	$.19	$.2
Revenue	$509.86M	$114.49M	$139.16M
Gross Profit	$312.42M	$80.75M	$88.82M
Net Income / Loss	$165.35M	$45.33M	$49.38M
Operating Income / Loss	$214.84M	$58.27M	$62.75M
Cost of Revenue	$197.45M	$33.74M	$50.35M
Net Cash Flow	$66.53M	$50.52M	$26.25M
PE Ratio